CRVL

Business Context and Reporting Period

Company: CorVel Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2005 (Third Quarter of Fiscal Year 2006)
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation and auto insurance policies. The company operates in a single reportable segment: managed care, offering patient management and network solutions services.

Key Financial Metrics

Note: For the three months ended December 31, 2005, revenues were $63.1 million and Net Income was $1.7 million.

Material Changes vs. Prior Period

• Revenue Decline: Revenues decreased 8.3% for the nine months ended December 31, 2005, compared to the prior year. This was driven by a 10.7% drop in patient management services and a 6.4% drop in network solutions, attributed to a soft national labor market, reduced workers' compensation claims, and increased competition.
• Margin Expansion: Despite lower revenues, gross profit margins improved from 15.4% to 16.5%. This was achieved through a favorable shift in business mix toward higher-margin network solutions and significant cost reductions, including a decrease in total headcount from 2,980 to 2,740.
• Profitability: Net income decreased 13.3% to $6.7 million. While gross profit remained relatively stable, General and Administrative (G&A) expenses increased 5.2% due to higher legal, regulatory, and corporate governance costs.
• Cash Flow: Operating cash flow increased to $21.8 million, primarily due to a reduction in accounts receivable of $8.1 million, improving Days Sales Outstanding (DSO) to 54.5 days.

Guidance, Outlook, and Risks

• Outlook: Management notes that challenging market conditions persist, with no guarantee of revenue growth. The company expects capital expenditure rates to remain similar to current levels unless revenues increase.
• Share Repurchases: The company has completed its authorized share repurchase program, having repurchased 7.1 million shares (43% of outstanding stock) for approximately $132 million. No further shares are currently authorized for repurchase.
• Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting as of March 31, 2005, resulting in a "disclaimer" opinion from auditors. Remediation efforts are underway, including hiring a Sarbanes-Oxley compliance officer and enhancing documentation and testing procedures.
• Accounting Changes: The company will adopt SFAS 123(R) regarding stock-based compensation in the quarter ending June 30, 2006, which will require expensing stock options and is expected to reduce reported net income.
• Risks: Key risks include changes in government regulations, potential litigation regarding medical treatment recommendations, competition from larger entities and in-house customer operations, and the potential for further revenue declines if workplace injury rates continue to fall.

Investor Verification Checklist

• Revenue Sustainability: Verify if the decline in workers' compensation claims volume is a temporary cyclical issue or a structural shift in the industry.
• Internal Control Remediation: Confirm the status of remediation efforts regarding the material weaknesses in financial reporting and whether the company has achieved an unqualified audit opinion for the fiscal year ending March 31, 2006.
• Impact of SFAS 123(R): Assess the projected impact of the new stock-based compensation accounting standard on future earnings per share.
• Share Repurchase Strategy: Determine if the Board will authorize a new share repurchase program given the completion of the current $132 million plan.
• Customer Concentration: Review the top customer list to ensure no single client represents a disproportionate risk, although the filing states no single customer accounted for 10% or more of receivables.